Issue
Number 610
July 17, 2006
CONTENTS OF THIS ISSUE
- CDC releases revised interim Tdap VIS
- AHA and ACC recommend influenza vaccination for patients
with cardiovascular disease
- CDC reports on 2004 varicella outbreak among vaccinated
children in Nebraska
- NACCHO devotes journal issue to seasonal and pandemic
influenza
- Clinical Vaccinology Course set for November 3–5 in
Atlanta
----------------------------------------------------------
Back to Top
---------------------------------------------------------------
ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American
Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices;
CDC, Centers for Disease Control and Prevention; FDA, Food and Drug
Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and
Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine
Information Statement; VPD, vaccine-preventable disease; WHO, World Health
Organization.
---------------------------------------------------------------
(1 of 5)
July 17, 2006
CDC RELEASES REVISED INTERIM Tdap VIS
On July 12, 2006, CDC released a revised interim Vaccine Information
Statement (VIS) for Tdap vaccine. It is identical to the previous interim
version except for minor changes in Section 3 that reflect ACIP's evolving
recommendations regarding use of Tdap during pregnancy.
It is not necessary to throw away copies of the previous version that have
already been printed; however, pregnant women considering getting the
vaccine should be made aware of the current recommendations.
A final Tdap VIS, an interim HPV VIS, an updated varicella VIS, and a zoster
VIS are all in development.
To download the new interim VIS for Tdap, or any other VIS in English, go to
CDC's VIS page at http://www.cdc.gov/nip/publications/VIS This page includes
a link to VIS news about new and upcoming releases.
For VISs in more than 30 languages, go to:
http://www.immunize.org/vis
---------------------------------------------------------------
Back to Top
(2 of 5)
July 17, 2006
AHA AND ACC RECOMMEND INFLUENZA VACCINATION FOR PATIENTS WITH CARDIOVASCULAR
DISEASE
On May 16, 2006, the American Heart Association (AHA) and the American
College of Cardiology (ACC) published guidelines for secondary prevention
for patients with coronary and other atherosclerotic vascular disease.
The paper states that a growing body of evidence supports the merits of
aggressive risk-reduction therapies for patients with established coronary
and other atherosclerotic vascular disease, including peripheral arterial
disease, atherosclerotic aortic disease, and carotid artery disease.
One of the intervention recommendations is that patients with cardiovascular
disease should receive influenza vaccination.
To read the complete article in the journal Circulation, go to:
http://circ.ahajournals.org/cgi/content/full/113/19/2363
---------------------------------------------------------------
Back to Top
(3 of 5)
July 17, 2006
CDC REPORTS ON 2004 VARICELLA OUTBREAK AMONG VACCINATED CHILDREN
IN NEBRASKA
CDC published "Varicella Outbreak Among Vaccinated Children—Nebraska, 2004"
in the July 14 issue of MMWR. A summary made available to the press is
reprinted below.
***********************
Varicella vaccine was 81 percent effective in preventing varicella during an
elementary school outbreak with significantly milder disease among
vaccinated students compared to unvaccinated students and warrants improving
varicella vaccination coverage. A varicella outbreak at an elementary school
in Nebraska in November 2004 raised concerns about vaccine failure among
vaccinated students. The public health investigation demonstrated that
vaccine effectiveness was within the expected range (80–85 percent) and
vaccinated cases had significantly milder disease. Since the licensure of
varicella vaccine in the United States in 1995 and the subsequent nationwide
implementation of a varicella vaccination program there has been a dramatic
decline in cases, hospitalizations, and deaths related to varicella.
However, varicella outbreaks continue to occur, involving both unvaccinated
and vaccinated cases as was the case in this outbreak too. Implementation of
broader school entry requirements (to include students from kindergarten to
college) can increase vaccination coverage and reduce varicella morbidity.
The Advisory Committee on Immunization Practices (ACIP) recently recommended
a second dose of varicella vaccine for children 4–6 years old and a second
dose catch-up vaccination for children, adolescents, and adults who
previously had received one dose. The second dose is expected to provide
protection to children. . . who do not adequately respond to the first dose
and have an impact on school outbreaks.
***********************
To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5527a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5527.pdf
To receive a FREE electronic subscription to MMWR (which includes new ACIP
statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
--------------------------------------------------------------
Back to Top
(4 of 5)
July 17, 2006
NACCHO DEVOTES JOURNAL ISSUE TO SEASONAL AND PANDEMIC INFLUENZA
The July–August 2006 issue of the Journal of Public Health Management and
Practice is devoted to seasonal and pandemic influenza. The issue editors
are Raymond A. Strikas, MD, and Nicole Smith, PhD, MPH, MPP. Both are with
CDC. The journal is published by NACCHO (National Association of County and
City Health Officials).
To access the article titles, go to:
http://www.naccho.org/pubs/documents/JPHMPflyer_000.pdf
To order the issue for $37.95, send an email message to
jransom@naccho.org
---------------------------------------------------------------
Back to Top
(5 of 5)
July 17, 2006
CLINICAL VACCINOLOGY COURSE SET FOR NOVEMBER 3–5 IN ATLANTA
The National Foundation for Infectious Diseases; the Emory Department of
Medicine, Division of Infectious Diseases; and the Emory Vaccine Center are
sponsoring a Clinical Vaccinology Course in Atlanta on November 3–5, 2006.
The course will provide the latest information on important developments in
clinical vaccinology and the use of vaccines. The course is designed for
physicians, nurses, physician assistants, pharmacists, vaccine program
administrators, and other health professionals involved with the clinical
use of vaccines. It will also present information of interest to public
health officials involved in the prevention and control of infectious
diseases.
For more information, including the agenda and list of course faculty, go
to:
http://www.nfid.org/conferences/idcourse06 Online registration is also
available via this web page. Alternatively, you can call (301) 656-0003,
extension 19, for more information. |
